FDA product code SJM: Quantitative Hepatitis B Surface Antigen

SJM is the FDA product code for quantitative hepatitis b surface antigen. It is a Class II device, regulated under 21 CFR 866.3177 and reviewed by the Microbiology panel. Devices under SJM reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A quantitative hepatitis B virus (HBV) surface antigen (HBsAg) test is an in vitro diagnostic device intended for prescription use for the quantitative determination of HBsAg in human serum, plasma, or other matrices specimens from individuals with HBV infection as an aid in the management of HBV-infected individuals including identifying patients who may benefit from treatment with appropriate antiviral therapies in accordance with the approved therapeutic product labeling.

Classification

FieldValue
Device nameQuantitative Hepatitis B Surface Antigen
Device classClass II
Regulation21 CFR 866.3177
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

Recalls for SJM devices

FDA recall records list no recalls for product code SJM.

Frequently asked questions

What is FDA product code SJM?

SJM is the FDA product code for quantitative hepatitis b surface antigen. It is a Class II device, regulated under 21 CFR 866.3177 and reviewed by the Microbiology panel.

What device class is SJM?

Class II, regulation 21 CFR 866.3177. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times